Skip to content

A clinical research based on multi-fMRI of acupuncture combined with SSRIs treating major depressive disorder

A clinical research based on multi-fMRI of acupuncture combined with SSRIs treating major depressive disorder

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005740
Enrollment
Unknown
Registered
2022-03-20
Start date
2022-03-31
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depression Disorder

Interventions

sham acupuncture+SSRIs:sham acupuncture
acupuncture+SSRIs:Acupuncture

Sponsors

Shuguang Hospital Attached with Shanghai Chinese Medicine University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Patients who meet the diagnostic criteria for depression in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by The American Psychological Association (APA) in 2013. 2) Between the ages of 18 and 65 years, regardless of gender 3) Score of >20 on the 24-item Hamilton Depression Inventory (HAMD24) and score of =2 on HAMD24 item 1 (depressed mood) 4) Clinical General Impression Inventory-Severity of Illness (CGI-S) score = 4 5) Right-handedness. 6) The patient understands and voluntarily accepts the treatment and signs an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Persons with a history of suicide attempts, serious suicidal ideation or high risk of self-injury within 1 year prior to the enrolment period 2) Those with a history of alcohol or other drug dependence or abuse within 1 year prior to the enrollment period 3) Those who have participated in a clinical trial of another drug within 3 months prior to the enrollment period 4) Those who have received electroconvulsive therapy, transcranial magnetic stimulation or other physiotherapy within 3 months prior to the enrolment period 5) Persons with other psychotic disorders such as bipolar disorder 6) Those with organic brain disease. 7) Those with other systemic disorders such as severe cardiovascular, endocrine or immune deficiencies 8) Women who are pregnant, preparing for pregnancy or breastfeeding 9) Those who, in the opinion of the investigator, are not suitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
HAMD24;

Secondary

MeasureTime frame
VAS;HAMA;PSQI;SERS;

Countries

China

Contacts

Public ContactGao Yuan

Shuguang Hospital affiliated with Shanghai University of TCM

494862608@qq.com13564898760

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026